Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name NEO-PV-01
Trade Name
Synonyms NEO PV 01|NEO-PV 01
Drug Descriptions

NEO-PV-01 is a personalized neoantigen vaccine that may stimulate anti-tumor immunity (Journal of Clinical Oncology 36, no. 15_suppl).

DrugClasses
CAS Registry Number NA
NCIT ID C129935

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + NEO-PV-01 + Pembrolizumab + Pemetrexed Disodium + Poly ICLC Carboplatin NEO-PV-01 Pembrolizumab Pemetrexed Disodium Poly ICLC 0 1
Ipilimumab + NEO-PV-01 + Nivolumab + Poly ICLC Ipilimumab NEO-PV-01 Nivolumab Poly ICLC 0 1
NEO-PV-01 NEO-PV-01 0 0
NEO-PV-01 + Nivolumab + Poly ICLC NEO-PV-01 Nivolumab Poly ICLC 0 1
NEO-PV-01 + Nivolumab + Poly ICLC + Sotigalimab NEO-PV-01 Nivolumab Poly ICLC Sotigalimab 0 1
NEO-PV-01 + Poly ICLC NEO-PV-01 Poly ICLC 0 1
NEO-PV-01 + Sotigalimab NEO-PV-01 Sotigalimab 0 0


Additional content available in CKB BOOST